Clinical Trial Update: Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update describing evaluation of intravenous immunoglobulin for managing hemolytic disease of the newborn due to Rh and ABO incompatibility in e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Disease of the Newborn

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Assiut University | Conditions: Haemolysis Neonatal | EARLY_Phase 1 | Status: UNKNOWN